ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC17741-50mg |
|
67469-78-7 |
Vanoxerine dihydrochloride
|
0 | C28H34Cl2F2N2O | |
GC17741-25mg |
|
67469-78-7 |
Vanoxerine dihydrochloride
|
0 | C28H34Cl2F2N2O | |
GC17741-10mg |
|
67469-78-7 |
Vanoxerine dihydrochloride
|
0 | C28H34Cl2F2N2O | |
GC17740-25mg |
|
2170-58-3 |
WB 4101 hydrochloride
|
0 | C19H23NO5.HCl | |
GC17739-50mg |
|
57568-80-6 |
PNU 37883 hydrochloride
|
0 | C21H35N3O.HCl | |
GC17739-10mg |
|
57568-80-6 |
PNU 37883 hydrochloride
|
0 | C21H35N3O.HCl | |
GC17738-10mg |
|
10335-69-0 |
MMP-2 Inhibitor I
|
0 | C18H35NO2 | |
GC17738-5mg |
|
10335-69-0 |
MMP-2 Inhibitor I
|
0 | C18H35NO2 | |
GC17737-10mM (in 1mL DMSO) |
|
152121-53-4 |
PD 169316
|
0 | C20H13FN4O2 | |
GC17737-50mg |
|
152121-53-4 |
PD 169316
|
0 | C20H13FN4O2 | |
GC17737-10mg |
|
152121-53-4 |
PD 169316
|
0 | C20H13FN4O2 | |
GC17736-1g |
|
55869-99-3 |
Anisodamine
|
0 | C17H23NO4 | |
GC17736-500mg |
|
55869-99-3 |
Anisodamine
|
0 | C17H23NO4 | |
GC17736-250mg |
|
55869-99-3 |
Anisodamine
|
0 | C17H23NO4 | |
GC17735-50mg |
|
109944-15-2 |
Kifunensine
|
0 | C8H12N2O6 | |
GC17735-10mg |
|
109944-15-2 |
Kifunensine
|
0 | C8H12N2O6 | |
GC17735-5mg |
|
109944-15-2 |
Kifunensine
|
0 | C8H12N2O6 | |
GC17735-1mg |
|
109944-15-2 |
Kifunensine
|
0 | C8H12N2O6 | |
GC17734-100mg |
|
13523-86-9 |
Pindolol
|
0 | C14H20N2O2 | |
GC17733-10mM (in 1mL DMSO) |
|
34580-14-8 |
Ketotifen Fumarate
|
0 | C23H23NO5S | |